Annotating off-label drug usage from unconventional sources
Avram, S.; Halip, L.; Curpan, R.; Borota, A.; Bora, A.; Oprea, T. I.
Show abstract
Physicians have the freedom to prescribe medicines outside the list of approved indications, to treat mild to life-threatening clinical conditions and diseases, particularly when conventional treatments fail or are lacking. Off-label drug usage is more frequently observed in specific populations not often represented in clinical trials, e.g., pediatric, geriatric, or pregnant patients. Despite conflicting reports on patient safety, exploring alternative treatment options in medical practice promotes innovation and extends the applicability of current medicines. This process can be significantly improved by properly documenting and discussing off-label usage. This paper aims to document off-label uses discussed in less conventional sources, such as the r/medicine Reddit subforum. We identified 66 "Reddit off-label uses" (ROLUs) not captured in our reference database, DrugCentral (https://drugcentral.org/), for a set of 40 drugs. These drugs are associated with 209 on-label drug indications (INDs) and 58 "non-Reddit" off-label uses (NROLUs). Most of these drugs are relatively old (approved before 2000) and act on the nervous system, many with psychiatric applications. However, ROLUs are distinct from INDs and NROLUs. An automated scientific literature query showed that 90% of the ROLUs are linked to 4 scientific publications or more, with 80% linked to at least 10. A further search in the clinical trials database revealed 46 ROLUs mentioned; 39 are in phase 3 trials. These results indicate that most off-label uses discussed on the Reddit forum are supported by scientific evidence. We conclude that medical social media channels can provide a valuable source of alternative drug applications and should be scientifically explored and evaluated in the future.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary 96%
- Sales of over-the-counter products containing codeine in 31 countries, 2013-2019: a retrospective observational study 94%
- Large-scale empirical identification of candidate comparators for pharmacoepidemiological studies 92%
Similar papers in this journal
Similar papers in this journal
- Preclinical Efficacy in Investigator’s Brochures: Stakeholders’ views on measures to improve Completeness and Robustness 93%
- Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022 - a repeated cross-sectional study 92%
- People exposed to proton pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: a nation-wide matched cohort study 91%
Similar papers in this journal
- Reported Drug Spectrum and Disproportionality Signals for Malignant Neoplasm Progression in FAERS: A Real-World Pharmacovigilance Study 91%
- A selective adenylyl cyclase 1 inhibitor relieves pain without causing tolerance 91%
- Real-world observation on response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.